4 results match your criteria: "and Retina Clinic[Affiliation]"
Mediators Inflamm
November 2022
Swiss Eye Institute, Rotkreuz, and Retina Clinic, Berner Augenklinik, Bern, Switzerland.
An imbalance of plasma apolipoproteins has been linked to diabetic retinopathy (DR); however, there is scarce information regarding their presence in the aqueous humor (AH) and their role in DR. Here, we aimed at analysing the relationship between apolipoprotein concentrations in human AH and the severity of DR. Concentrations of apolipoproteins were measured retrospectively in patients with type 2 diabetes mellitus (T2DM) without DR ( = 23), with mild to moderate nonproliferative DR (NPDR) ( = 13), and advanced NPDR/proliferative DR (PDR) ( = 14) using a multiplex immunoassay.
View Article and Find Full Text PDFMediators Inflamm
January 2022
Swiss Eye Institute, Rotkreuz and Retina Clinic, Berner Augenklinik am Lindenhofspital, 3012, Switzerland.
Diabetic retinopathy (DR) is a sight-threatening late complication of diabetes mellitus (DM). Even though its pathophysiology has not been fully elucidated, several studies suggested a role for transforming growth factor- (TGF-) , matrix metalloproteinases (MMPs), and tissue inhibitors of matrix metalloproteinase (TIMP) in the onset and progression of the disease. Consequently, the aim of this study was to analyze the concentrations of TGF-1, TGF-2, TGF-3, MMP-3, MMP-9, and TIMP-1 in patients with different stages of DR in order to identify stage-specific changes in their concentrations during the progression of the disease.
View Article and Find Full Text PDFJ Clin Med
May 2021
Swiss Eye Institute, Rotkreuz, and Retina Clinic, Berner Augenklinik am Lindenhofspital, 3012 Bern, Switzerland.
The aim of this paper is to summarise our own and to review published experience regarding the long-term outcome of intravitreal treatment for macular neovascularisation (MNV) secondary to Sorsby's fundus dystrophy (SFD). A systematic literature search using the MeSH terms [Sorsby] and [anti-vascular endothelial growth factor (VEGF)] was conducted in NCBI/PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), ScienceDirect, Google Scholar and ClinicalTrials.gov to identify publications reporting anti-VEGF treatment outcomes in SFD.
View Article and Find Full Text PDFRetina
September 2016
*Department of Ophthalmology and Visual Sciences, Paulista School of Medicine (EPM), Federal University of São Paulo (UNIFESP), São Paulo, Brazil; †Hospital Garcia de Orta, Almada, Portugal; and ‡Retina Clinic, São Paulo, Brazil.
Purpose: To evaluate outcomes and complications of pars plana vitrectomy in patients with epiretinal membrane secondary to toxoplasmic retinochoroiditis.
Methods: Retrospective evaluation of the records of 14 patients who underwent pars plana vitrectomy for epiretinal membrane secondary to toxoplasmic retinochoroiditis. The best-corrected visual acuity, intraoperative and postoperative complications, and macular optical coherence tomography were analysed.